Your strategic partner in laboratory services for:Precision Oncology
We operate as Central Lab and Local Lab in Argentina and the region. We process routine, biomarkers, molecular biology and anatomic pathology under ICH-GCP, with a single point of contact per study.
15+
Years in clinical research
120+
Active studies
30+
Years in operation
Track record
The experience a well-designed study requires.
0+
Years in clinical research
Partnering with local and global sponsors
0+
Active studies
Acting as Central Lab and Local Lab in parallel
0+
Years in operation
Aclimu has been operating since 1994
Capabilities
Routine and specialty, all under one roof.
One chain of custody, one SOP set, one sponsor interface. No need to pass samples through third parties.
PBMC processing + cryopreservation
Isolation of peripheral blood mononuclear cells, viability assessment, aliquoting and storage at -80 °C / LN₂ vapor phase. Traceable cold chain from sample reception.
Routine clinical chemistry
Hematology, clinical chemistry, liver panel, renal function, thyroid panel, hormones and inflammation markers under quality standards.
Specialty biomarkers
Immunoassays, ELISA, flow cytometry, multiplex PCR and HPLC.
Molecular biology and pharmacogenomics
PCR / qPCR, genotyping, gene panels via NGS, MLPA and Array CGH.
Anatomic pathology
Histopathology, immunohistochemistry and digital pathology with slide digitization for remote sponsor review.
PK/PD bioanalysis
Quantification of drug in plasma and biological matrices. Pharmacokinetic and pharmacodynamic curves with validated methods.
Sample journey
End-to-end traceability, sample by sample.
1 / 5
Step 01
Protocol-specific kit at the site
Ready-to-ship kit
We assemble collection kits tailored to the protocol: tubes, blinded ID labels, instructions and a shipping request.
Per protocol
Kits tailored to the study
Quality and compliance
Audit-ready any time.
We operate under local and international standards your sponsor or CRO already knows. Each one covers a specific layer: technical, regulatory, data, and transport.
ITAES
Institutional accreditation
Healthcare quality accreditation by the Argentine Institute for Healthcare Establishment Accreditation.
ICH-GCP E6 R3
Good Clinical Practice
We apply the latest (2023) global standard for clinical trial design and conduct.
GLP
Good Laboratory Practice
OECD GLP applied to non-clinical and preclinical studies.
IATA DGR
Biological substances UN3373
Personnel trained in preparation, labeling and international shipping of biological samples.
Law 25.326
Personal data
Compliance with the Argentine privacy law and GDPR considerations for European sponsors.
Trained team
Continuous training
The full team holds the sector's required certifications: GCP, IATA DGR, biosafety, sample handling and any study-specific training required.
Documentation
Online and downloadable
Methods, reference values, current versions and traceability for every determination: available online for sponsors and CROs whenever needed.
Scientific leadership
Real people, credentials visible.
Every study has a single point of contact and a responsible technical director. No call-center layers between your CRO and the person signing the report.
Technical Director
Dr. Jonatan García
Responsible for the laboratory's technical direction. Leads method validation processes for multi-site studies and holds all sector certifications required for clinical research.
Areas of expertise
Infrastructure and technology
Validated processes, real-time data.
Operational quality · panel
Today's queue
updated now
Obtained
Final val.
Repeated
Latest samples
ACL-26-09-2341Final validated09:42ACL-26-09-2340Tech validated09:28ACL-26-09-2339Repeated09:15ACL-26-09-2338Final validated08:51ACL-26-09-2337In process08:30
23 obtained · 18 tech validated · 15 final validated today
Study phases
We support Phase I to IV.
Phase I
First-in-human
Small cohorts focused on safety and dosing. We operate as Central Lab with validated methods for PK/PD and safety panels.
Phase II
Exploratory efficacy
Biomarkers and efficacy endpoints. Cross-site harmonization and statistical support for interim analyses.
Phase III
Pivotal confirmation
High volume, multi-site. Aclimu integrates into the global trial network or leads the South American region as a local hub.
Phase IV
Post-approval / real-world
Post-market surveillance and effectiveness studies. We process large batches with predictable SLAs.
Start a conversation
Every project starts with a good conversation.
We want to understand what you need to solve. We'll respond with a clear proposal — timeline, scope and costs. If we decide to move forward, we'll handle the formal side.
Direct contact
Single point of contact per study
Write to us
clinicaltrials@aclimu.com.ar
Open under NDA. Share the protocol when signed and we'll respond in detail.

